These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34969875)

  • 1. Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need.
    Guo LN; Perez-Chada LM; Borucki R; Nambudiri VE; Werth VP; Merola JF
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34969875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome measures for cutaneous lupus erythematosus.
    Albrecht J; Werth VP
    Lupus; 2010 Aug; 19(9):1137-43. PubMed ID: 20693208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for cutaneous disease in systemic lupus erythematosus.
    Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on clinical trials for cutaneous lupus erythematosus.
    Xie L; Lopes Almeida Gomes L; Stone CJ; Faden DF; Werth VP
    J Dermatol; 2024 Jul; 51(7):885-894. PubMed ID: 38491743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.
    Bonilla-Martinez ZL; Albrecht J; Troxel AB; Taylor L; Okawa J; Dulay S; Werth VP
    Arch Dermatol; 2008 Feb; 144(2):173-80. PubMed ID: 18283174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures.
    Jolly M; Kazmi N; Mikolaitis RA; Sequeira W; Block JA
    J Am Acad Dermatol; 2013 Apr; 68(4):618-623. PubMed ID: 23107310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus.
    Albrecht J; Werth VP
    Dermatol Ther; 2007; 20(2):93-101. PubMed ID: 17537137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
    Chen KL; Krain RL; Werth VP
    F1000Res; 2019; 8():. PubMed ID: 30984372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cutaneous disease activity in early lupus and its correlation with quality of life: a cross-sectional study.
    Hinduja N; Mv P; Padhee S; Maikap D; Padhan P; Kar HK; Misra R; Srinivas CR; Ahmed S
    Rheumatol Int; 2023 Oct; 43(10):1835-1840. PubMed ID: 37310437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biological therapeutic approaches to cutaneous lupus erythematosus.
    Tayer-Shifman OE; Rosen CF; Wakani L; Touma Z
    Expert Opin Biol Ther; 2018 Oct; 18(10):1041-1047. PubMed ID: 30118337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus.
    Ogunsanya ME; Kalb SJ; Kabaria A; Chen S
    Br J Dermatol; 2017 Jan; 176(1):52-61. PubMed ID: 27416958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the EUSCLE Core Set Questionnaire for the assessment of cutaneous lupus erythematosus.
    Kuhn A; Patsinakidis N; Bonsmann G
    Lupus; 2010 Aug; 19(9):1144-52. PubMed ID: 20693209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicohistological and immunopathological features of patients with cutaneous lupus erythematosus at tertiary dermatology centre in Malaysia.
    Teh YC; Loo CH; Mohd Ali N; Lim AL; Tan WC
    Clin Exp Dermatol; 2022 Aug; 47(8):1490-1501. PubMed ID: 35315538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologists.
    Kushner CJ; Tarazi M; Gaffney RG; Feng R; Ardalan K; Brandling-Bennett HA; Castelo-Soccio L; Chang JC; Chiu YE; Gmuca S; Hunt RD; Kahn PJ; Knight AM; Mehta J; Pearson DR; Treat JR; Wan J; Yeguez AC; Concha JSS; Patel B; Okawa J; Arkin LM; Werth VP
    Br J Dermatol; 2019 Jan; 180(1):165-171. PubMed ID: 30033560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
    J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study.
    Samotij D; Szczęch J; Antiga E; Bonciani D; Caproni M; Chasset F; Dańczak-Pazdrowska A; Furukawa F; Hasegawa M; Hashizume H; Ikeda T; Islam A; Kim HJ; Lesiak A; Misery L; Mowla MR; Polańska A; Szepietowski JC; Tsuruta D; Verdelli A; Werth VP; Reich A
    Lupus; 2021 Aug; 30(9):1385-1393. PubMed ID: 34000879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus.
    Md Yusof MY; Britton J; Edward S; Hensor EMA; Goodfield MJ; Laws PM; Emery P; Wittmann M; Vital EM
    Lupus; 2019 Oct; 28(11):1320-1328. PubMed ID: 31522626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
    Zhou W; Wu H; Zhao M; Lu Q
    Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expert consensus achieved on a working core outcome set for cutaneous lupus erythematosus research in survey following the 5th International Conference on Cutaneous Lupus Erythematosus (ICCLE).
    Zhang AJ; Perez-Chada LM; Werth VP; Merola JF
    Lupus Sci Med; 2024 Feb; 11(1):. PubMed ID: 38413096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.